Alerzin 5mg 14 tablets — Made in Hungary — Free Delivery

Alerzin tablets are used for the symptomatic treatment of allergic rhinitis (including year-round allergic rhinitis) and urticaria.

The active ingredient is levocetirizine dihydrochloride (one tablet contains 5 mg of levocetirizine dihydrochloride, which corresponds to 4.21 mg of levocetirizine).

Excipients: silicon microcrystalline cellulose, low-substituted hydroxypropyl cellulose, lactose monohydrate, magnesium stearate; shell composition: Opadry II 33G28523 white (hypromellose, titanium dioxide (E 171), macrogol 3350, triacetylglycerol, lactose monohydrate).

hypersensitivity to levocetirizine, cetirizine, hydroxyzine, to any other piperazine derivatives or to any other excipient of the preparation;

severe chronic renal failure (creatinine clearance <10 ml / minute);

rare hereditary diseases of galactose intolerance, lactase deficiency or impaired absorption of glucose and galactose.

The preparation is prescribed for adults and children over 6 years of age.

Recommended doses:

adults and children over 12 years old - the daily dose is 5 mg (one coated tablet) once a day;

children aged 6 to 12 years - the recommended daily dose is 5 mg (one coated tablet).

For children from 2 to 6 years old, it is impossible to adjust the dose of the preparation in the dosage form of a tablet.

Method of use: take a tablet by mouth, regardless of food intake. The tablet must be swallowed whole with a little water. It is recommended to apply the daily dose at one time.

Patients with recurrent allergic rhinitis (duration of symptoms of the disease is less than 4 days per week or for less than 4 weeks per year) should be treated in accordance with the disease and history; treatment can be discontinued if symptoms disappear and can be restored if symptoms recur. In the case of persistent allergic rhinitis (the duration of the symptoms of the disease is more than 4 days a week and for more than 4 weeks a year) during the period of contact with allergens, the patient may be offered continuous therapy. There is clinical experience with levocetirizine for at least 6 months of treatment.

In chronic diseases (chronic allergic rhinitis, chronic urticaria), the duration of treatment is up to one year (data are available from clinical studies using cetirizine (racemate)).

Pregnant

Levocetirizine is contraindicated during pregnancy. Levocetirizine passes into breast milk, therefore, if it is necessary to use the preparation, breastfeeding should be discontinued. There are no clinical data (including animal studies) on the effect of levocetirizine on fertility.

Children

The preparation in the form of tablets should not be used in children under 6 years of age, since this dosage form does not allow for the necessary correction of the dosage regimen. For this category of patients, it is recommended to use levocetirizine in a dosage form suitable for use in pediatrics.

Drivers

You should refrain from driving or operating machinery during treatment.

Symptoms

Overdose symptoms may include drowsiness in adults and initial agitation and irritability followed by drowsiness in children.

Treatment

There is no specific antidote to levocetirizine. In case of symptoms of an overdose, symptomatic and supportive therapy is recommended. Consideration should be given to the need for gastric lavage shortly after taking the preparation. Hemodialysis is not effective for removing levocetirizine from the body.

From the nervous system: drowsiness, headache, fatigue, weakness, asthenia, convulsions, paresthesia, dizziness, fainting, tremor, dysgeusia.

From the side of the psyche: sleep disturbance, agitation, hallucinations, depression, aggression, insomnia, suicidal thoughts, bad dreams.

From the heart: increased heartbeat, tachycardia.

From the side of the organs of vision: visual impairment, blurred vision, oculogyration.

On the part of the hearing and balance organs: vertigo.

From the liver and biliary tract: hepatitis.

From the kidneys and urinary system: dysuria, urinary retention.

From the immune system: hypersensitivity, including anaphylaxis.

From the respiratory system, chest and mediastinal organs: shortness of breath.

From the gastrointestinal tract: diarrhea, vomiting, constipation, dry mouth, nausea, abdominal pain.

On the part of the skin and subcutaneous tissues: angioedema, persistent preparation rash, itching, rash, urticaria.

From the musculoskeletal system, connective tissue and bones: myalgia, arthralgia.

Eating and metabolic disorders: increased appetite.

Itching has been reported after discontinuation of levocetirizine.